Literature DB >> 26819055

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.

Brian G Engelhardt1, Sophie Paczesny2, Dae Kwang Jung1, Etienne Daguindau2, Madan Jagasia1, Bipin N Savani1, Wichai Chinratanalab1, Robert F Cornell1, Stacey Goodman1, John P Greer1, Adetola A Kassim1, Salyka Sengsayadeth1, Sandra M Yoder3, Michael T Rock3, James E Crowe4.   

Abstract

Entities:  

Keywords:  allogeneic hematopoietic cell transplantation; early Th1 immunity; graft-versus-leukemia effect; immune tolerance

Mesh：

Year:  2016        PMID： 26819055      PMCID： PMC5004357          DOI： 10.3324/haematol.2015.139501

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.

Authors:  Jeffrey Weber
Journal:  Semin Oncol       Date:  2010-10       Impact factor: 4.929

2.  IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells.

Authors:  Sang-Keun Lee; Sam-Hwa Seo; Byoung-Soo Kim; Chang-Deok Kim; Jeung-Hoon Lee; Jung-Soo Kang; Pil Jae Maeng; Jong-Soon Lim
Journal:  J Dermatol Sci       Date:  2005-08-08       Impact factor: 4.563

3.  Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells.

Authors:  Raewyn Broady; Jie Yu; Vickie Chow; Adisak Tantiworawit; Christine Kang; Kyra Berg; Magdalena Martinka; Mehran Ghoreishi; Jan Dutz; Megan K Levings
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

4.  In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.

Authors:  Michael J Carlson; Michelle L West; James M Coghill; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

5.  Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

Authors:  Brian G Engelhardt; Salyka M Sengsayadeth; Madan Jagasia; Bipin N Savani; Adetola A Kassim; Pengcheng Lu; Yu Shyr; Sandra M Yoder; Michael T Rock; James E Crowe
Journal:  Exp Hematol       Date:  2012-08-10       Impact factor: 3.084

6.  Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Authors:  W J Murphy; L A Welniak; D D Taub; R H Wiltrout; P A Taylor; D A Vallera; M Kopf; H Young; D L Longo; B R Blazar
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

7.  Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

Authors:  Y G Yang; B R Dey; J J Sergio; D A Pearson; M Sykes
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

Review 8.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

Review 9.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

10.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.